-
Mashup Score: 0The Lipid Panel | National Lipid Association Online - 7 hour(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1The Lipid Panel | National Lipid Association Online - 17 day(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1The Lipid Panel | National Lipid Association Online - 1 month(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 12| National Lipid Association Online - 1 month(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 7Grants & Sponsorships - 1 month(s) ago
Learn more about each of the different grant programs with IONIS, qualifications and requirements for each, and deadlines for submissions.
Source: www.ionispharma.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 64A Focused Update to the 2019 NLA Scientific Statement on Use of Lipoprotein(a) in Clinical Practice | National Lipid Association Online - 2 month(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 19Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol | Regeneron Pharmaceuticals Inc. - 2 month(s) ago
Approval extends treatment of Praluent to children aged 8 and older with heterozygous familial hypercholesterolemia (HeFH) TARRYTOWN, N.Y. , March 11, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food & Drug Administration (FDA) has extended the
Source: investor.regeneron.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1The Lipid Panel | National Lipid Association Online - 2 month(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 15Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data - 2 month(s) ago
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has initiated an Expanded Access Program (EAP) to make investigational plozasir
Source: www.businesswire.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 15Connecting the Dots: Inflammation's Impact on ASCVD and CKD | National Lipid Association Online - 2 month(s) ago
National Lipid Association
Source: www.lipid.orgCategories: General Medicine News, Cardiology News and JournTweet
📢 ICYMI! Our Lipid Panel webinar is tomorrow night at 8pm ET! Dive deep into Polycystic Ovary Syndrome with Dr. Merle Myerson and panelists Dr. Kathleen Wyne and Dr. Guy Mintz! Don't miss out. ✍️ #PCOSWebinar Register at https://t.co/gcI7b7aoTf https://t.co/ROtfaaeuOs